IMAB logo

NovaBridge Biosciences (IMAB)

Profile

Full Name

NovaBridge Biosciences

Ticker

NASDAQ: IMAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 17, 2020

Indexes

Not included

Website

https://www.i-mabbiopharma.com

Employees

32

Key Details

Price

$4.16(-8.17%)

Market Cap

$479.51M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(-100.00% YoY)

Annual EPS

-$0.70(72.03% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.16
    IMAB price is $4.16

    30-Day Relative Volume

    0.59
    IMAB 30-day relative volume is 0.59

    Price Performance

    Price Most Recent Change

    -8.17%
    IMAB price was down -8.17% on Nov 20, 2025

    Price YTD Change

    +389.41%
    IMAB price is up +389.41% since January 1st

    Price 1-Year Change

    +333.79%
    IMAB price is up +333.79% year-on-year

    Price 3-Year Change

    +11.83%
    IMAB price is up +11.83% over the past 3 years

    Price Range

    Price All-Time High

    $85.40
    IMAB price is currently -95.13% below its historical high of $85.40

    Price 3-Year Low

    $0.59
    IMAB price is currently +599.16% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $479.51M
    IMAB market cap is $479.51 million

    Market Cap 3-Year Change

    +55.12%
    IMAB market cap is up +55.12% over the past 3 years

    Market Cap All-Time High

    $6.50B
    IMAB market cap is currently -92.62% below its historical high of $6.50 billion

    Market Cap Sector Percentile

    -
    IMAB market cap is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +41.43%
    IMAB shares outstanding is up +41.43% year-on-year

    Shares Outstanding 3-Year Change

    +38.71%
    IMAB shares outstanding is up +38.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.76
    IMAB beta is 0.76

    200-day SMA

    $2.54
    IMAB price is currently +63.82% above its 200-day simple moving average

    50-day SMA

    $4.43
    IMAB price is currently -6.06% below its 50-day simple moving average

    14-Day RSI

    44.27
    IMAB 14-day relative strength index is 44.27

    Volume

    0.59
    IMAB 30-day relative volume is 0.59

    ATR

    $0.45
    IMAB average true range is $0.45

    10-day Historical Volatility

    72.31%
    IMAB 10-day historical volatility is 72.31%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    IMAB annual revenue is $0.00

    Revenue Analysts Estimate

    -
    IMAB annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -100%
    IMAB annual revenue is down -100% year-on-year

    Revenue Sector Percentile

    -
    IMAB annual revenue is unknown

    EPS

    EPS

    -$0.70
    IMAB annual earnings per share is -$0.70

    EPS Analysts Estimate

    -$0.31
    IMAB annual earnings per share is currently -122.60% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +72.03%
    IMAB annual earnings per share is up +72.03% year-on-year

    EPS Sector Percentile

    -
    IMAB annual earnings per share is unknown

    Profit

    Gross Profit

    -$978.00K
    IMAB annual gross profit is -$978.00 thousand

    Gross Margin

    -
    IMAB annual gross profit margin value is unknown

    Operating Profit

    -$50.15M
    IMAB annual operating income is -$50.15 million

    Operating Margin

    -
    IMAB annual operating profit margin value is unknown

    Net Income

    -$49.72M
    IMAB annual net profit is -$49.72 million

    Net Margin

    -
    IMAB annual net profit margin value is unknown

    Expenses

    Total Expenses

    $50.15M
    IMAB annual total expenses is $50.15 million

    Operating Expenses

    $50.15M
    IMAB annual total operating expenses is $50.15 million

    Cost Of Goods Sold

    $978.50K
    IMAB annual cost of goods sold is $978.50 thousand

    Selling, General & Administrative Expenses

    $29.66M
    IMAB annual SG&A is $29.66 million

    Depreciation & Amortization

    $978.00K
    IMAB annual D&A is $978.00 thousand

    Interest Expense

    $0.00
    IMAB annual interest expense is $0.00

    Income Tax

    $0.00
    IMAB annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$50.15M
    IMAB annual earnings before interest & taxes is -$50.15 million

    EBITDA

    -$49.17M
    IMAB annual EBITDA is -$49.17 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $212.68M
    IMAB annual total assets is $212.68 million

    Non Current Assets

    $35.99M
    IMAB annual long term assets is $35.99 million

    Current Assets

    $176.69M
    IMAB annual total current assets is $176.69 million

    Cash and Cash Equivalents

    $68.26M
    IMAB annual cash & cash equivalents is $68.26 million

    Accounts Receivable

    -
    IMAB annual accounts receivable value is unknown

    Inventory

    $0.00
    IMAB annual inventory is $0.00

    Liabilities

    Total Liabilities

    $11.52M
    IMAB annual total liabilities is $11.52 million

    Long Term Liabilities

    $3.07M
    IMAB annual total long term liabilities is $3.07 million

    Current Liabilities

    $8.45M
    IMAB annual current liabilities is $8.45 million

    Accounts Payable

    $0.00
    IMAB annual accounts payable is $0.00

    Debt

    Total Debt

    $3.88M
    IMAB annual total debt is $3.88 million

    Total Debt 1-Year Change

    -0.13%
    IMAB annual total debt is down -0.13% year-on-year

    Long Term Debt

    $3.07M
    IMAB annual long term debt is $3.07 million

    Short Term Debt

    $816.00K
    IMAB annual short term debt is $816.00 thousand

    Equity & Capital

    Shareholders Equity

    $201.16M
    IMAB annual stockholders equity is $201.16 million

    Book Value

    $201.16M
    IMAB annual book value is $201.16 million

    Retained Earnings

    -$1.29B
    IMAB annual retained earnings is -$1.29 billion

    Working Capital

    $168.24M
    IMAB annual working capital is $168.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$52.67M
    IMAB annual cash from operations is -$52.67 million

    Cash From Operations 1-Year Change

    +27.55%
    IMAB annual cash from operations is up +27.55% year-on-year

    Cash From Investing

    -$136.01M
    IMAB annual cash from investing is -$136.01 million

    Cash From Investing 1-Year Change

    -796.96%
    IMAB annual cash from investing is down -796.96% year-on-year

    Cash From Financing

    -$335.00K
    IMAB annual cash from financing is -$335.00 thousand

    Cash From Financing 1-Year Change

    +95.93%
    IMAB annual cash from financing is up +95.93% year-on-year

    CAPEX

    CAPEX

    $48.00K
    IMAB annual capital expenditures is $48.00 thousand

    CAPEX 1-Year Change

    -70.73%
    IMAB annual capital expenditures is down -70.73% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$52.72M
    IMAB annual free cash flow is -$52.72 million

    Free Cash Flow 1-Year Change

    +27.65%
    IMAB annual free cash flow is up +27.65% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    IMAB annual gross profit margin value is unknown

    Operating Margin

    -
    IMAB annual operating profit margin value is unknown

    Net Margin

    -
    IMAB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -17.10%
    IMAB annual return on assets is -17.10%

    ROE

    -22.41%
    IMAB annual return on equity is -22.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    IMAB price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    IMAB price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.44
    IMAB price to book ratio is 2.44

    PB Ratio Sector Percentile

    -
    IMAB price to book ratio is unknown

    PS Ratio

    PS Ratio

    -
    IMAB price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    IMAB price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $317.37M
    IMAB enterprise value is $317.37 million

    Enterprise Value Sector Percentile

    -
    IMAB enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    IMAB EV/EBITDA value is unknown

    EV/EBITDA Sector Percentile

    -
    IMAB EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    20.90
    IMAB annual current ratio is 20.90

    Quick Ratio

    20.90
    IMAB annual quick ratio is 20.90

    Leverage

    Debt To Equity

    0.02
    IMAB annual debt to equity ratio is 0.02

    Interest Coverage Ratio

    -
    IMAB annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    IMAB piotroski f-score value is unknown

    Altman Z-Score

    16.68
    IMAB altman z-score is 16.68

    Analyst ratings

    Recent major analysts updates

    Oct 24, 25 BTIG
    Buy
    Oct 17, 25 BTIG
    Buy
    Oct 3, 25 Leerink Partners
    Outperform
    Sep 10, 25 BTIG
    Buy
    Sep 9, 25 BTIG
    Buy
    Sep 8, 25 Needham
    Buy
    Aug 21, 25 HC Wainwright & Co.
    Buy
    Aug 20, 25 Needham
    Buy
    Jul 9, 25 Needham
    Buy
    Jul 9, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IMAB included

    No data
    • What is the ticker symbol for NovaBridge Biosciences?
    • Does NovaBridge Biosciences pay dividends?
    • What sector is NovaBridge Biosciences in?
    • What industry is NovaBridge Biosciences in?
    • What country is NovaBridge Biosciences based in?
    • When did NovaBridge Biosciences go public?
    • Is NovaBridge Biosciences in the S&P 500?
    • Is NovaBridge Biosciences in the NASDAQ 100?
    • Is NovaBridge Biosciences in the Dow Jones?
    • When was NovaBridge Biosciences's last earnings report?
    • When does NovaBridge Biosciences report earnings?

    What is the ticker symbol for NovaBridge Biosciences?

    The ticker symbol for NovaBridge Biosciences is NASDAQ:IMAB

    Does NovaBridge Biosciences pay dividends?

    No, NovaBridge Biosciences does not pay dividends

    What sector is NovaBridge Biosciences in?

    NovaBridge Biosciences is in the Healthcare sector

    What industry is NovaBridge Biosciences in?

    NovaBridge Biosciences is in the Biotechnology industry

    What country is NovaBridge Biosciences based in?

    NovaBridge Biosciences is headquartered in United States

    When did NovaBridge Biosciences go public?

    NovaBridge Biosciences's initial public offering (IPO) was on January 17, 2020

    Is NovaBridge Biosciences in the S&P 500?

    No, NovaBridge Biosciences is not included in the S&P 500 index

    Is NovaBridge Biosciences in the NASDAQ 100?

    No, NovaBridge Biosciences is not included in the NASDAQ 100 index

    Is NovaBridge Biosciences in the Dow Jones?

    No, NovaBridge Biosciences is not included in the Dow Jones index

    When was NovaBridge Biosciences's last earnings report?

    NovaBridge Biosciences's most recent earnings report was on November 12, 2025

    When does NovaBridge Biosciences report earnings?

    The date for NovaBridge Biosciences's next earnings report has not been announced yet
    On this page